The factory in Manesar will produce rapid tests for infectious diseases like dengue, malaria and HIV and export them across Asia Pacific, a region heavily impacted by these diseases, Khattar said as he inaugurated the facility in the presence of Namal Nawana, CEO and President of Alere firm.
The Manesar facility will initially produce more than 150 million rapid diagnostic tests per year and will have the capacity to expand to 300 million test.
The 180,000 square-feet factory in Manesar will initially employ approximately 300 people.
"Alere's new facility will support the goals of our 'Make in India' initiative, which seeks to transform India into a global manufacturing hub. Efforts to foster and expand India's medical device sector are important not only to our economic growth, but also to improve the health of the people of India," Nawana said.
"Alere believes in Prime Minister Narendra Modi's vision of 'Make in India' and is committed to improving access to affordable rapid diagnostics in India and throughout the Asia Pacific region through this new world-class manufacturing facility," Nawana said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
